Home › Leg Injuries and Disorders › NCT06337292
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures: A Multicenter Randomized Controlled Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. All open or closed tibial plateau or pilon fractures treated operatively with internal fixation at high risk for complication. Any open Gustilo Type I, II or IIIA tibial shaft fracture treated definitively with internal or external fixation with or without ipsilateral leg compartment syndrome if at least one wound is primarily closed. 2. We define high-risk fractures as those that are either: * Closed fracture initially treated with an external fixator (with or without limited internal fixation) and treated definitive more than 3 days later after swelling has resolved; * Any open type I, II or IIIA fracture, regardless of timing of definitive treatment; * Any tibial plateau fracture associated with ipsilateral leg compartment syndrome fasciotomy wounds that has at least one wound primarily closed 3. Requiring incision for fixation or debridement of 3 cm or greater. 4. Patients 18 years of age or older Exclusion Criteria: 1. The study injury is already infected at time of study enrollment. 2. Patient is unable to receive incisional NPWT for any reason. 3. Patients who have already had definitive fixation prior to enrollment in the study. 4. Severe problems with maintaining follow-up (e.g., patients who are homeless at the time of injury or those who are intellectually challenged without adequate family support or who are prisoners). 5. The study injury is a Gustilo Type IIIB or IIIC open fracture.
About the study
This is a multi-center, pragmatic, parallel arm randomized controlled trial (RCT) of 352 patients with high-risk open or closed tibial plateau fracture, high-risk open or closed tibial pilon fracture, or open tibial shaft fracture with incision \>3cm. Eligible participants will be randomized to receive either incisional negative pressure wound therapy (NPWT) or a non-suction standard-of-care wound dressing for their definitive wound management. The primary outcome will be a composite outcome to evaluate clinical status 3 months after randomization.
What is being tested
- Incisional Negative Pressure Wound Therapy (NPWT) (device)
Sponsor: Major Extremity Trauma Research Consortium · Participants: 352 · Started: Jan 1, 2025
Contact the study team
- Leah Gitajn, MD · Phone: 603-650-5133
Official record on ClinicalTrials.gov — NCT06337292
Locations in the U.S.
| Maryland | University of Maryland R Adams Cowley Shock Trauma Center, Baltimore University of Maryland Shock Trauma/Capitol Regions, Baltimore |
| New Hampshire | Dartmouth-Hitchcock Medical Center, Lebanon |
| Tennessee | Vanderbilt University, Nashville |
| Texas | UTHealth/McGovern Medical School, Houston |
| Virginia | Inova Fairfax MEdical Campus, Falls Church |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.